Other companies may be struggling to meet expectations for financial performance, but not Varian Medical Systems. On April 8, the company said its earnings for 2Q 2003 would rise 35% to 40% over the year-ago quarter. Previously, the company estimated 26%
Other companies may be struggling to meet expectations for financial performance, but not Varian Medical Systems. On April 8, the company said its earnings for 2Q 2003 would rise 35% to 40% over the year-ago quarter. Previously, the company estimated 26% growth for the quarter. The better-than-expected earnings reflect a recovery much stronger than was anticipated in the x-ray products business, according to Varian. The company is also reporting continued strength in its oncology business. The strong quarter puts annual company earnings per diluted share for fiscal 2003 on track to grow by 29% to 31% over fiscal 2002 totals.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.